ES8506045A1 - Procedimiento para la preparacion de 17-halogenoetinilesteroides - Google Patents

Procedimiento para la preparacion de 17-halogenoetinilesteroides

Info

Publication number
ES8506045A1
ES8506045A1 ES531900A ES531900A ES8506045A1 ES 8506045 A1 ES8506045 A1 ES 8506045A1 ES 531900 A ES531900 A ES 531900A ES 531900 A ES531900 A ES 531900A ES 8506045 A1 ES8506045 A1 ES 8506045A1
Authority
ES
Spain
Prior art keywords
preparation
formula
pregnan derivatives
pregnan
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES531900A
Other languages
English (en)
Other versions
ES531900A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES531900A0 publication Critical patent/ES531900A0/es
Publication of ES8506045A1 publication Critical patent/ES8506045A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 17-HALOGENOETINIL-ESTEROIDES, DE FORMULA (I), EN LA QUE R1 ES HIDROGENO O METILO; X ES BROMO O YODO; Y R2 Y V PUEDEN SER VARIOS RADICALES.CONSISTE EN LA REACCION DE UN ETILESTEROIDE DE FORMULA (II), EN LA QUE R1, R2 Y V SON LOS MISMOS QUE EN LA FORMULA (I), CON UN AGENTE HALOGENANTE, EN UN DISOLVENTE INERTE, EN PRESENCIA DE UNA SAL DE PLATA, A UNA TEMPERATURA ENTRE 0JC Y 50JC.ESTOS COMPUESTOS TIENEN APLICACIONES COMO INTERMEDIOS EN LA PREPARACION DE CORTICOIDES.
ES531900A 1983-04-25 1984-04-25 Procedimiento para la preparacion de 17-halogenoetinilesteroides Expired ES8506045A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833315324 DE3315324A1 (de) 1983-04-25 1983-04-25 Verfahren zur herstellung von 17(alpha)-(br oder j)-ethinyl-17ss-or-steroiden

Publications (2)

Publication Number Publication Date
ES531900A0 ES531900A0 (es) 1985-07-01
ES8506045A1 true ES8506045A1 (es) 1985-07-01

Family

ID=6197529

Family Applications (1)

Application Number Title Priority Date Filing Date
ES531900A Expired ES8506045A1 (es) 1983-04-25 1984-04-25 Procedimiento para la preparacion de 17-halogenoetinilesteroides

Country Status (15)

Country Link
US (1) US4567002A (es)
EP (1) EP0123241B1 (es)
JP (1) JPS6034990A (es)
AT (1) ATE41160T1 (es)
CA (1) CA1254883A (es)
CS (1) CS252474B2 (es)
DD (1) DD221460A5 (es)
DE (2) DE3315324A1 (es)
DK (1) DK206684A (es)
ES (1) ES8506045A1 (es)
FI (1) FI841620A (es)
GR (1) GR81486B (es)
HU (1) HU193568B (es)
PL (1) PL143460B1 (es)
SU (1) SU1389681A3 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3434448A1 (de) * 1984-09-17 1986-03-27 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur herstellung von pregnan-derivaten
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
CA2081205C (en) * 1990-06-11 2001-02-27 John W. Wilks Steroids which inhibit angiogenesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3067214A (en) * 1960-04-20 1962-12-04 Merck & Co Inc Haloethisterone compounds
US3211725A (en) * 1960-04-20 1965-10-12 Merck & Co Inc 6alpha-methyl-21 halo nor ethisterones and intermediates in the preparation thereof
US3347880A (en) * 1962-10-05 1967-10-17 Schering Corp 17alpha-halogenoethinylestranes
DE2625306C2 (de) * 1976-06-02 1978-06-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von Pregnan-Derivaten
DE3242892C1 (de) * 1982-11-16 1984-07-12 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 17alpha-(Br oder J)-ethinyl-17ss-hydroxysteroiden

Also Published As

Publication number Publication date
ATE41160T1 (de) 1989-03-15
DK206684A (da) 1984-10-26
FI841620A0 (fi) 1984-04-25
FI841620A (fi) 1984-10-26
US4567002A (en) 1986-01-28
ES531900A0 (es) 1985-07-01
SU1389681A3 (ru) 1988-04-15
CS252474B2 (en) 1987-09-17
DD221460A5 (de) 1985-04-24
EP0123241A1 (de) 1984-10-31
PL143460B1 (en) 1988-02-29
DK206684D0 (da) 1984-04-25
GR81486B (es) 1984-12-11
HUT34215A (en) 1985-02-28
EP0123241B1 (de) 1989-03-08
DE3477000D1 (en) 1989-04-13
JPS6034990A (ja) 1985-02-22
HU193568B (en) 1987-10-28
DE3315324A1 (de) 1984-10-31
CA1254883A (en) 1989-05-30
PL247376A1 (en) 1985-04-09
CS307084A2 (en) 1987-01-15

Similar Documents

Publication Publication Date Title
ES8700254A1 (es) Un procedimiento para la preparacion de aminoalcoxibenzopiranonas.
ES8600263A1 (es) Un compuesto.
CA1022942A (en) Process for spheroidization of rdx crystals
DE2860196D1 (en) Process for the preparation of low molecular polyhydroxy compounds
ES8705411A1 (es) Procedimiento para preparar derivados de 1-piperazinacarboxamida
ES8506045A1 (es) Procedimiento para la preparacion de 17-halogenoetinilesteroides
ES452444A1 (es) Un procedimiento para la preparacion de composiciones utilespara el control de la vegetacion indeseable.
ES8504703A1 (es) Un metodo para la preparacion de nuevos derivados de fenilbutilaldehido
ES8304135A3 (es) Procedimiento de obtencion de benzhidrilpiperazinas
IT1088559B (it) 2,5-dimercapto-1,3,4-tiadiazolo quale reticolatore per polimeri saturi contenenti alogeni
ES458389A1 (es) Procedimiento para preparar derivados de prostaglandina.
IT1099980B (it) 2,5-dimercapto-1,3,4-tiadiazolo quale reticolatore per polimeri saturi contenenti alogeni
ES8102560A1 (es) Procedimiento para la preparacion de hexametilenimino carbo-tioles
ES8302648A1 (es) "procedimiento de preparacion de 2-oxo-1-pirrolidinilacetatos de 3,3,5-trimetilciclohexilo".
ES8303445A1 (es) "procedimiento para la preparacion de derivados c-glicosidicos de halometiltiazoles".
AU530964B2 (en) Composition for treatment of eczema
ES8106503A1 (es) Procedimiento para la obtencion de compuestos heterociclicosnitrogenados
ES482304A1 (es) Procedimiento para la obtencion de nuevos derivados de mono y dio-oxoquinoxalinas.
JPS5239697A (en) Synthesis of l-and dl-p-n-butoxybenzyl- 6,7-dehydrohyosciaminium bromi de
JPS532476A (en) Synthesis of 4-substituted-dithio-2-azetidinone derivatives
ES461174A1 (es) Procedimiento para la preparacion de 3-azidometil-2,9-dioxa-triciclo (4,3,1,0 3,7) decanos.
AU495131B2 (en) Chemical compositions for treating water
ES8402568A1 (es) Procedimiento para la obtencion de 13-tia-prostaciclinas.
ES444954A1 (es) Un procedimiento para la preparacion de la 2-oxo-1-pirroli- dinacetamida.
ES478050A1 (es) Procedimiento para la preparacion de 1-metil-isoguanosina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020401